汇宇制药：持股5%以上股东被动减持130万股股份

Core Viewpoint - The announcement from Huiyu Pharmaceutical indicates that shareholder Huang Qianyi has reduced his stake in the company due to judicial enforcement actions, impacting his overall shareholding percentage and total shares held [1] Group 1: Shareholding Details - Huang Qianyi held 27,219,439 shares before the reduction, representing 6.426% of the total share capital [1] - Following the reduction, Huang Qianyi now holds 25,919,439 shares, which is 6.119% of the total share capital [1] Group 2: Reduction Specifics - The reduction occurred between February 9 and 10, 2026, through centralized bidding transactions [1] - A total of 1,300,000 shares were sold, accounting for 0.307% of the current total shares [1] - The share reduction was executed at a price range of 19.41 to 19.77 yuan per share, resulting in a total amount of 25.4803 million yuan [1] Group 3: Compliance and Plan - The share reduction was completed in accordance with relevant regulations and aligned with the previously announced reduction plan [1]